SCHEMBL5235008

SCHEMBL5235008

O=C(O)c1ccc(NC(=O)c2ccccc2Cc2ccccc2)cc1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.50
▸ ADRB2 P07550 1/20 0.50
▸ AVPR2 P30518 1/20 0.49
▸ OXTR P30559 1/20 0.49
▸ AVPR1A P37288 1/20 0.49
▸ BCL2 P10415 1/20 0.49
▸ SMN1; SMN2 Q16637 3/20 0.48
▸ KDM4E B2RXH2 3/20 0.48
▸ LMNA P02545 1/20 0.48
▸ TSHR P16473 1/20 0.47
▸ PARP1 P09874 2/20 0.46
▸ PARG Q86W56 1/20 0.46
▸ MAPT P10636 3/20 0.46
▸ GAA P10253 2/20 0.46
▸ SMO Q99835 1/20 0.46
▸ NPC1 O15118 3/20 0.46
▸ RAB9A P51151 3/20 0.46
▸ MEN1 O00255 3/20 0.46
▸ KMT2A Q03164 3/20 0.46
▸ NFKB1 P19838 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5739660 0.91 ALDH1A1 (0.49) ALDH1A1ADRB2BCL2SMN1; SMN2KDM4E
SCHEMBL27502192 0.89 ALDH1A1 (0.67) ALDH1A1ADRB2AVPR2OXTRAVPR1A
SCHEMBL5738843 0.88 MEN1 (0.49) ALDH1A1ADRB2BCL2SMN1; SMN2KDM4E
SCHEMBL12700230 0.83 ALDH1A1 (0.64) ALDH1A1AVPR2OXTRAVPR1ASMN1; SMN2
SCHEMBL7331517 0.81 DHODH (0.68) ALDH1A1AVPR2OXTRAVPR1ASMN1; SMN2
SCHEMBL8971238 0.80 ALDH1A1 (0.73) ALDH1A1ADRB2BCL2SMN1; SMN2KDM4E
SCHEMBL5238436 0.80 TSHR (0.65) ALDH1A1ADRB2BCL2SMN1; SMN2KDM4E
SCHEMBL5233758 0.79 TSHR (0.63) ALDH1A1ADRB2BCL2SMN1; SMN2KDM4E
SCHEMBL5236516 0.77 ALDH1A1 (0.57) ALDH1A1ADRB2BCL2SMN1; SMN2KDM4E
SCHEMBL1458777 0.77 CHRNB2 (0.63) ALDH1A1AVPR2AVPR1AKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0804440-B1 TRICYCLIC BENZAZEPINE VASOPRESSIN ANTAGONISTS WYETH CORP (US) 2007-12-19 — — EP disclosed
EP-0804438-B1 TRICYCLIC BENZAZEPINE VASOPRESSIN ANTAGONISTS WYETH CORP (US) 2006-03-15 — — EP disclosed
CN-1061658-C Tricyclic benzazepine vasopressin antagonists AMERICAN CYANAMID CO (US) 2001-02-07 — — CN disclosed
CN-1231666-A Tricyclic benzazepine vasopressin antagonists AMERICAN CYANAMID CO (US) 1999-10-13 — — CN disclosed
CN-1181084-A Tricyclic benzazepine vasopression antagonists AMERICAN CYANAMID CO (US) 1998-05-06 — — CN disclosed
US-5612334-A Tricyclic benzazepine vasopressin antagonists AMERICAN CYANAMID COMPANY (US) 1997-03-18 — — US disclosed
US-5610156-A USED IN TREATING DISEASES CHARACTERIZED BY EXCESS RENAL REABSORPTION OF WATER AMERICAN CYANAMID COMPANY (US) 1997-03-11 — — US disclosed
WO-1996022293-A1 TRICYCLIC BENZAZEPINE VASOPRESSIN ANTAGONISTS AMERICAN CYANAMID COMPANY (US) 1996-07-25 — — WO disclosed
WO-1996022282-A1 TRICYCLIC BENZAZEPINE VASOPRESSIN ANTAGONISTS AMERICAN CYANAMID COMPANY (US) 1996-07-25 — — WO disclosed
WO-1996022295-A1 TRICYCLIC BENZAZEPINE VASOPRESSIN ANTAGONISTS AMERICAN CYANAMID COMPANY (US) 1996-07-25 — — WO disclosed
US-5536718-A Tricyclic benzazepine vasopressin antagonists AMERICAN CYANAMID COMPANY (US) 1996-07-16 — — US disclosed
US-5532235-A TO TREAT EXCESS RENAL REABSORPTION AMERICAN CYANAMID COMPANY (US) 1996-07-02 — — US disclosed
Send feedback